Women are 50–75% more likely to have adverse drug reactions—a new mouse study finally helps explain why
Compared to men, we know much less about how women experience disease.
Dec 12, 2022
0
1064
Compared to men, we know much less about how women experience disease.
Dec 12, 2022
0
1064
The effect of medicines on women and men can differ significantly. This also applies to the currently most promising anti-aging drug rapamycin, as researchers from the Max Planck Institute for Biology of Ageing in Cologne ...
Dec 1, 2022
0
184
A review of the international use of a commonly prescribed family of antibiotics has found discrepancies in the safety data issued by regulatory bodies.
Dec 1, 2022
0
17
Faulty batches of generic lamotrigine tablets—an anti-convulsant drug commonly used for treating bipolar disorder and epilepsy—are being dispensed to patients in Australia. The compromised product is likely a result of ...
Nov 30, 2022
0
25
Scientists from The Australian National University (ANU) have detected a mysterious new recreational drug not seen in Australia before, nor toxicologically described anywhere else.
Oct 19, 2022
0
28
The growing list of COVID complications is long and surprising—from brain changes and heart disease to skin rashes and COVID toes.
Oct 13, 2022
0
4
Malaria is caused by the parasite Plasmodium falciparum, which is transmitted by mosquitos. The World Health Organization (WHO) estimates that in 2020, there were 241 million cases and 627,000 deaths worldwide, 94% of cases ...
Oct 13, 2022
0
7
As of late September 2022, nearly 78% of U.S. adults but only 31% of children ages 5 to 11 had completed the primary set of vaccinations against COVID-19, according to health authorities.
Oct 3, 2022
0
15
Although many people with dietary allergies experience mild symptoms when exposed to triggering foods, some face potentially fatal consequences. A bacterial compound called butyrate that's made by healthy microbiomes has ...
Aug 21, 2022
1
209
The U.S. Food and Drug Administration granted regular approval to capmatinib (Tabrecta) for adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have a genetic mutation leading to mesenchymal-epithelial ...
Aug 15, 2022
0
6